Pharminent

J&J pondering future of diabetes device assets

Three diabetes
care subsidiaries under review as firm forecasts measured 2017 sales http://www.pmlive.com/pharma_news/j_and_j_pondering_future_of_diabetes_device_assets_1185016

Filed under: Diabetes